Anaplastic Large Cell Lymphoma Study
COG #ANHL0131 A Phase lll Trial of Treatment of Advanced-Stage Anaplastic Large Cell Lymphoma (ALCL) with Standard APO (Doxorubicin, Prednisone, Vincristine) versus Consolidation with a Regimen Including Vinblastine
Protocol ID
03.10.175T
Protocol Description
The goals of this study are:
• To see if substituting the drug Vinblastine for the standard drug Vincristine in treating anaplastic large cell lymphoma (ALCL) will result in more patients achieving and staying in remission.
• To gain more understanding of the biology of ALCL and how certain biological markers might relate to treatment outcome.
Eligibility Criteria
Children and adolescents with anaplastic large cell lymphoma (ALCL)
Primary Investigator(s)
- Arlene Redner, MD